Senior Clinical
Equibles does not estimate personal net worth.
Get an email with a short summary when Karyopharm Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get KPTI alertsAbout Senior Clinical
Senior Clinical is recorded as CEO at Karyopharm Therapeutics Inc. (KPTI). The proxy statement of Karyopharm Therapeutics Inc. reports total compensation of $3,937,039 for Senior Clinical in fiscal 2020, including a base salary of $625,624. Disclosed compensation is on record for 2 fiscal years. Karyopharm Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Karyopharm Therapeutics Inc. includes Richard Paulson (CEO and Board Member), Michael Mano (General Counsel), Kristin Abate (Chief Accounting Officer) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Karyopharm Therapeutics Inc.
- Richard Paulson CEO, Board Member
- Michael Mano General Counsel
- Kristin Abate Chief Accounting Officer
- Barry E. Greene Board Member
- Chen Schor Board Member
- Christy J Oliger Board Member
- Christy J. Oliger Board Member
- Deepika R. Pakianathan Board Member
- Garen G. Bohlin Board Member
- Mansoor Raza Mirza M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Karyopharm Therapeutics Inc. (KPTI) | Advisor and Former Chief Executive Officer | $625,624 | $3,937,039 |
| 2019 | Karyopharm Therapeutics Inc. (KPTI) | Advisor and Former Chief Executive Officer | $566,500 | $3,231,504 |
Recent activity
No call appearances or filed executive changes recorded yet.